New patent for the drug Esperion Theraps NEXLIZET – DrugPatentWatch
Annual Drug Patent Expiration for NEXLIZET
Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from a single supplier. There are seven patents protecting this drug.
NEXLIZET drug price trend.
This drug has forty-four patent family members in twenty-two countries.
The generic ingredient in NEXLIZET is bempedoic acid; ezetimibe. One registered supplier for this compound. Additional details are available on bempedoic acid; ezetimibe profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Esperion Theraps NEXLIZET
